Minneapolis-based Medtronic, a medical device manufacture, has agreed to pay $362,362 to 46 states and the
The lawsuit against Medtronic alleged the company improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease.
The lawsuit was originally filed under the qui tam, or whistle-blower, provision of the False Claims Act.
Medtronic has agreed to pay the settling states a combined $362,362, which will be distributed to those states' Medicaid programs.
More articles on healthcare industry lawsuits:
Detroit area physician admits providing medically unnecessary chemotherapy as part of $225M fraud scheme
Gilead Sciences faces False Claims Act case alleging defective-drug fraud
7 recent healthcare industry lawsuits, settlements